Scribe Therapeutics (Nasdaq: SCTX) said on July 23, 2026 it priced an upsized initial public offering of 8,580,000 shares at $15.00 per share, expecting gross proceeds of $128.7 million. The shares are slated to begin trading on the Nasdaq Global Market on July 24, 2026 under the symbol “SCTX.” The company also agreed to sell 500,000 shares at $15.00 per share in a concurrent private placement to Sanofi. Scribe is a clinical-stage CRISPR gene-editing biotechnology company focused on cardiometabolic disease and does not have a marketed product or revenue.

International Gemological Institute (IGI) reported a 31% year-on-year rise in Q1FY27 consolidated net profit to Rs 1,657 Mn, while revenue increased 23% to Rs 3,708 Mn. EBITDA rose 29% to Rs 2,238 Mn and the EBITDA margin widened to 60.35%. Certification volumes grew 17% to 3.56 Mn reports, and average realized price per report increased 5% to Rs 1,010. The company operates in a single segment focused on diamond, gemstone and jewellery certification.

Thyrocare Technologies reported Q1FY27 consolidated net profit of ₹51.33 crore, up 34% year on year. Revenue climbed to ₹240.02 crore, an increase of 24.3%. The EBITDA margin expanded by 230 basis points to 32.2%, while test volumes rose to 55.2 million, up 28%.

Temasek-backed Manipal Health Enterprises is preparing to launch a $1-billion initial public offering in late July, with the price band set to be announced on July 24. The share sale is expected to open for subscription from July 29 to July 31. The offering includes a fresh issue worth up to ₹8,000 crore and an offer-for-sale of up to 4.32 crore shares by promoters and existing investors.

Pivot Integrated Energy Services Limited has launched a commercial paper issuance of up to N100bn as the first series under its broader N300bn Commercial Paper Programme. Proceeds will be used for working capital to support the importation, trading, storage, distribution and supply of refined petroleum products across Nigeria and selected African markets. Pivot is one of 20 approved offtakers under the Dangote Refinery PMS Consortium with an allocated target volume of 300 million litres per quarter. Credit rating agencies have assigned short-term ratings ranging from A1 to A3.

Newmont reported June-quarter sales of US$6,118 million and net income attributable to shareholders of US$2,202 million, or US$2.06 per diluted share, sharply higher year on year. The company said the result was supported by a higher average realised gold price of US$4,414 per ounce, which helped offset lower quarterly gold production of 1.2 million ounces and higher all-in sustaining costs of US$1,938 per ounce. Free cash flow for the half year was US$5,349 million, and Newmont ended the quarter with US$9,009 million in cash. It also declared a quarterly dividend of US26c per share and continued stock repurchases.

U.S. cotton futures finished mostly higher on Thursday, with deferred contracts up as much as 74 points. Gains came as forecasts pointed to very limited precipitation across much of Texas and the Southeast over the next week. Weekly 2025/26 export sales rebounded to 51,287 running bales, with China and Vietnam the top buyers. The Cotlook A Index rose 160 points to 89.60 cents/lb, while ICE certified stocks were unchanged.

U.S. wheat futures broadly moved lower on Thursday, with key CBOT and KCBT contracts down 3–13 cents. USDA export sales data showed weekly wheat exports of 290,000 tons, down more than 50% from a year earlier. Spring wheat tour estimates put yield at 48 bushels per acre, above the five-year average but below last year. Together, the figures point to marginally improved supply and softer demand, adding pressure to prices.